Camstech

Camstech, established in 2014, is a biotechnology company that specializes in developing and commercializing novel sensing technologies for medical diagnostics and biotechnology applications. The company operates from the Campus Technology Hub at Daresbury Laboratory and has its roots in the CERN Business Incubation Centre at Harwell Campus in Oxfordshire. The core product is a miniature multi-analyte Point of Care Testing (PoCT) instrument that provides quantitative diagnostic information at a low cost per test, comparable to traditional strip sensors. This technology is particularly advantageous for identifying biomarkers that are already approved for medical diagnostics and is adaptable for future markers as they emerge. The company serves clients in the medical diagnostics and biotechnology sectors, offering a scalable and cost-effective solution for quantitative testing. Camstech's business model revolves around the licensing of its manufacturing technology, which was initially developed at CERN and is now being used in the Large Hadron Collider (LHC) upgrade. This licensing strategy allows the company to produce its sensors at highly competitive costs, thereby making its technology accessible to a broader market. The company generates revenue through the sale of its PoCT instruments and the licensing of its proprietary technology.

Keywords: biotechnology, medical diagnostics, PoCT, sensors, scalable technology, biomarkers, CERN, LHC, quantitative testing, cost-effective.